2023-08-10 09:10:28 ET
- Motus GI Holdings Inc ( NASDAQ: MOTS ) on Thursday said it has received approval from the Israeli Ministry of Health, Medical Device Division to initiate commercial sales of the Pure-Vu EVS System in Israel..
- The Pure-Vu EVS is already cleared by U.S. Food and Drug Administration (FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy.
- MOTS +4.98% after hours to $0.6168.
- Source: Press Release
For further details see:
Motus GI receives approval from Israeli Ministry of Health to initiate commercial sales of Pure-Vu EVS system